Patents Assigned to Anthony G. Gristina
  • Patent number: 5292513
    Abstract: A non-specific host defense cell augmentation technique for enhanced microorganism killing utilizes any phagocytosable, biocompatible particle to prime macrophages for enhanced oxidative response and bacterial killing. Patients can have the benefits of primed macrophages in one to four days, and experiments have demonstrated over a 100-fold increase in oxidative potential within this time period. The oxidative response and killing potential is non-immunospecific, meaning not one organism, not a vaccine, and broadly applicable simultaneously to bacteria and viruses as well as tumor cells. The effects have been demonstrated to have a seven day duration indicating non-tissue toxic residual effects and potential for repeated use at monthly intervals.
    Type: Grant
    Filed: May 18, 1992
    Date of Patent: March 8, 1994
    Assignee: Anthony G. Gristina
    Inventors: Anthony G. Gristina, Quentin N. Myrvik